A two-phase, multicenter, open-label, "first-in-human" prospective study evaluating the product's safety and efficacy in a pivotal phase.
Study Type
OBSERVATIONAL
Enrollment
20
FN HK
Hradec Králové, Czechia
Incidence of anastomotic leak
(Grade B, C according to the International Study Group of Rectal Cancer)
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.